To the Editor: The article on utilisation of pathology procedures in the South African private pathology sector, published in the SAMJ recently, (1) refers. Solutions are proposed that have no bearing on the ‘factual’ material presented, and apersions are cast designed to advance the aspirations of Veripath, a commercial managed care enterprise. The conclusions have long been the credo of Veripath and are not based on the claims database surveyed. Veripath input is acknowledged, but the author should indicate that he is a full-time employee of the managed care company. [Dr Pretorius declared his relationship with Veripath and the medical aid industry in a letter accompanying the original submission of his article.–Editor] Bias and vested interest flaws any useful examination of the material by the author or his cohorts. Although the information bears examination, any extrapolation is flawed because the baselines are neither decided nor constant. The SAMJ has been used as a platform to advance not scientific conclusions, but a thinly veiled sales pitch that is being touted to advance their credibility. The CPD questionnaire seems to indicate that the article has been accepted as the final word on the topic. It cannot be. There is no dearth of published articles on laboratory utilisation, but when new pathology tests seem to arrive almost every day, articles published up to 33 years ago might not be entirely relevant except to advance vested interests!